Inhibition of P-Glycoprotein Function and Expression by Kaempferol and Quercetin

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of chemotherapy

• Publication date

  2005-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1179/joc.2005.17.1.86PMID 15828450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Literature Review

  2006cited by this paper
• Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target

  2004cited by this paper
• Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids

  2004cited by this paper
• SCREENING OF FLAVONOIDS FOR THEIR POTENTIAL INHIBITORY EFFECT ON P-GLYCOPROTEIN ACTIVITY IN HUMAN CERVICAL CARCINOMA KB CELLS

  2004cited by this paper
• BMC Cancer

  2003cited by this paper
• Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships.

  2002cited by this paper
• Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.

  2002cited by this paper
• Ceramide glycosylation potentiates cellular multidrug resistance

  2001cited by this paper
• Comparison of in vitro growth-inhibitory activity of carboplatin and cisplatin on leukemic cells and hematopoietic progenitors: the myelosuppressive activity of carboplatin may be greater than its antileukemic effect.

  2000cited by this paper
• Effect of bioflavonoids on vincristine transport across blood-brain barrier.

  2000cited by this paper
• Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract.

  1999cited by this paper
• Suppression of multidrug resistance via inhibition of heat shock factor by quercetin in MDR cells

  1998cited by this paper
• Apoptosis and the dilemma of cancer chemotherapy.

  1997cited by this paper
• Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein.

  1997cited by this paper
• Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein.

  1997cited by this paper
• Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.

  1996cited by this paper
• Resistance mechanisms and their regulation in lung cancer.

  1996cited by this paper
• Mechanisms of Multidrug Resistance

  1995cited by this paper
• Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes.

  1995cited by this paper
• EPIDEMIOLOGICAL CHARACTERISTICS OF PROSTATE CANCER IN GUNMA PREFECTURE, JAPAN

  1995cited by this paper
• Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism.

  1994cited by this paper
• Detection of soluble P-glycoprotein in culture media and extracellular fluids.

  1994cited by this paper
• Differential modulation of P-glycoprotein transport by protein kinase inhibition.

  1993cited by this paper
• Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.

  1993cited by this paper
• Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells.

  1993cited by this paper
• Heat‐shock responsive elements in the induction of the multidrug resistance gene (MDR1)

  1992cited by this paper
• Activation of human multidrug resistance-1 gene promoter in response to heat shock stress.

  1992cited by this paper
• Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis.

  1992cited by this paper
• P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.

  1991cited by this paper
• What's new in cytostatic drug resistance and pathology.

  1991cited by this paper
• Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factors.

  1990cited by this paper
• Glutathione S-transferases and drug resistance.

  1990cited by this paper
• The biochemistry of P-glycoprotein-mediated multidrug resistance.

  1989cited by this paper
• Enhanced efflux of [3H]vinblastine from Chinese hamster ovary cells transfected with a full-length complementary DNA clone for the mdr1 gene.

  1989cited by this paper
• The multidrug transporter, a double-edged sword.

  1988cited by this paper
• Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins.

  1986cited by this paper
• Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.

  1986cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Improvement of the Intestinal Absorption of Dihydroquercetin (DHQ) by Flavonoids via Inhibiting P-Glycoprotein (P-gp)-Mediated Efflux in P-gp Overexpressed KB/MDR1 Cells and Caco-2 Monolayers.

  2026cites this paper
• Discovery of drug transporter inhibitors tied to long noncoding RNA in resistant cancer cells; a computational model -in silico- study

  2025cites this paper
• Docetaxel and quercetin-loaded lipid nanocarrier optimized by quality by design for glioblastoma therapy: a ligand-conjugated and therapeutic repurposing approach

  2025cites this paper
• Much More than Nutrients: The Protective Effects of Nutraceuticals on the Blood–Brain Barrier in Diseases

  2025cites this paper
• Quinine-chalcone hybrids as potent inhibitors of P-glycoprotein with apoptotic effects on EBC-1 cells.

  2025cites this paper
• Flavonoids as Bioenhancers: A Critical Review on Their Potential to Improve Drug Delivery and Therapeutic Outcomes

  2025cites this paper
• Anti-proliferative and Pro-apoptotic Activity of a Novel Oil-in-Water Nanoemulsion Containing Tea Tree Oil, Quercetin, and Rosmarinic Acid in Breast Cancer Cells

  2025cites this paper
• Active tumor targeting by core-shell PDMS-HA nanoparticles with sequential delivery of doxorubicin and quercetin to overcome P-glycoprotein efflux pump.

  2025cites this paper
• Fabrication of curcumin-loaded nano-micelles based on quercetin-quarternary ammonium-chitosan (Qu-QCS) conjugate and evaluation of synergistic effect with doxorubicin against breast cancer.

  2024cites this paper
• Cytotoxic and antioxidant effects of paclitaxel and glutathione combination on breast cancer cell line

  2024cites this paper
• Modulation of membrane transporter expression and activity by mangiferin, epigallocatechin-3-gallate (EGCG), quercetin, and kaempferol: A review

  2024influential citation
• Role of Natural Phytoconstituents as a Potential Bioenhancer of Anti-Cancer and Anti-Microbial Agents: Spotlight on the Mechanism of Action, Clinical Studies and Patents

  2024cites this paper
• Therapeutic potential of silica nanoparticles, cisplatin, and quercetin on ovarian cancer: In vivo model.

  2024cites this paper
• Attenuation of TNF-α and Iron Levels in Renal Hemosiderosis by Phaleria macrocarpa (Scheff.) Boerl Extract in a Rat Iron Overload Model

  2024cites this paper
• Synergistic effects of flavonoids and paclitaxel in cancer treatment: a systematic review

  2023influential citation
• Potential Targets and Mechanisms of Bitter Almond-Licorice for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking

  2023cites this paper
• Quercetin modulates signal transductions and targets non-coding RNAs against cancer development.

  2023cites this paper
• New era of nanoparticles facilitated co-delivery in cancer therapy: two heads are better than one

  2023cites this paper
• Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies

  2023cites this paper
• Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets

  2022cites this paper
• Biomimetic and temporal-controlled nanocarriers with ileum transporter targeting for achieving oral administration of chemotherapeutic drugs

  2022cites this paper
• Modulation of p-glycoprotein-mediated efflux pirarubicin in living multidrug-resistant K562/Dox cell lines by 4-hydroxybenzoic acid and 4-hydroxy-3-methoxybenzoic acid via impairment of the cellular energetic state

  2022cites this paper
• Efficacy of Flavonoids in Combating Fluconazole Resistant Oral Candidiasis.

  2022cites this paper
• Human gut Actinobacteria boost drug absorption by secreting P-glycoprotein ATPase inhibitors

  2022cites this paper
• Nanomaterials loaded with Quercetin as an advanced tool for cancer treatment

  2022cites this paper
• The complex relationship between multiple drug resistance and the tumor pH gradient: a review

  2022cites this paper
• Natural Blockers of PD-1/PD-L1 Interaction for the Immunotherapy of Triple-Negative Breast Cancer-Brain Metastasis

  2022cites this paper
• A state-of-the-art review and prospective therapeutic applications of prenyl flavonoids as chemosensitizers against antifungal multidrug resistance in Candida albicans.

  2022cites this paper
• Extract of Codiaeum luzonicum Merr. overcomes multidrug resistance in human colon cancer cells by modulating P-glycoprotein

  2022cites this paper
• Therapeutic Importance of Kaempferol in the Treatment of Cancer through the Modulation of Cell Signalling Pathways

  2022cites this paper
• Pharmacokinetic Outcomes of the Interactions of Antiretroviral Agents with Food and Supplements: A Systematic Review and Meta-Analysis

  2022cites this paper
• Paclitaxel-Containing Extract Exerts Anti-Cancer Activity through Oral Administration in A549-Xenografted BALB/C Nude Mice: Synergistic Effect between Paclitaxel and Flavonoids or Lignoids

  2022cites this paper
• Why Do Dietary Flavonoids Have a Promising Effect as Enhancers of Anthracyclines? Hydroxyl Substituents, Bioavailability and Biological Activity

  2022cites this paper
• Differentiation-Inducing Activity of the Phyto-polyphenols Epigallocatechin-3-gallate and Kaempferol on NB4 Cells

  2021cites this paper
• Potential Mechanisms of Plant-Derived Natural Products in the Treatment of Cervical Cancer

  2021cites this paper
• Transporter-mediated Natural Product-Drug Interactions

  2021cites this paper
• Structure-activity relationship and mechanism of flavonoids on the inhibitory activity of P-glycoprotein (P-gp)-mediated transport of rhodamine123 and daunorubicin in P-gp overexpressed human mouth epidermal carcinoma (KB/MDR) cells.

  2021cites this paper
• A comparative study of anti-leukemic effects of kaempferol and epigallocatechin-3-gallate (EGCG) on human leukemia HL-60 cells

  2021cites this paper
• LIPID NANOCARRIER OF SELEGILINE AUGMENTED ANTI-PARKINSON'S EFFECT VIA P-GP MODULATION USING QUERCETIN.

  2021cites this paper
• A novel flavonoid from Fissistigma cupreonitens, 5‑hydroxy‑7,8‑dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance.

  2021cites this paper
• The role of dietary flavonoids for modulation of ATP binding cassette transporter mediated multidrug resistance

  2021cites this paper
• Phytochemicals reverse P-glycoprotein mediated multidrug resistance via signal transduction pathways.

  2021cites this paper
• Sweet cherry phenolics revealed to be promising agents in inhibiting P-glycoprotein activity and increasing cellular viability under oxidative stress conditions: in vitro and in silico study.

  2021cites this paper
• Anti-cancer potential of cannabis terpenes in a taxol-resistant model of breast cancer

  2021cites this paper
• Isoflavones in Soybean as a Daily Nutrient: The Mechanisms of Action and How They Alter the Pharmacokinetics of Drugs.

  2020cites this paper
• Efflux pumps as interventions to control infection caused by drug-resistance bacteria.

  2020cites this paper
• Quercetin and cervical cancer: a view of great scope

  2020cites this paper
• A cell-based high-throughput screen identifies inhibitors that overcome P-glycoprotein (Pgp)-mediated multidrug resistance

  2020cites this paper
• Computer-Aided Drug Design Applied to Secondary Metabolites as Anticancer Agents.

  2020cites this paper
• Defying Multidrug Resistance! Modulation of Related Transporters by Flavonoids and Flavonolignans.

  2020cites this paper
• Quercetin acts as a P-gp modulator via impeding signal transduction from nucleotide-binding domain to transmembrane domain

  2020cites this paper
• Impact of quercetin on pharmacokinetics of quetiapine: insights from in-vivo studies in wistar rats

  2020cites this paper
• Cholinesterase Inhibitory Potential of Quercetin towards Alzheimer’s Disease - A Promising Natural Molecule or Fashion of the Day? - A Narrowed Review

  2020cites this paper
• Plant-Based Drugs as an Adjuvant to Cancer Chemotherapy

  2020cites this paper
• Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.

  2020cites this paper
• Enhancement of Loading Efficiency by Co-loading of Doxorubicin and Quercetin in Thermoresponsive Polymeric Micelles.

  2020cites this paper
• Chemotherapeutic Efficacy Enhancement in P-gp-Overexpressing Cancer Cells by Flavonoid-Loaded Polymeric Micelles

  2020cites this paper
• Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update.

  2020cites this paper
• Research Progress in Flavonoid Anticancer Drugs including synergy with other Approaches.

  2020cites this paper
• Drug Bioavailability Enhancing Agents of Natural Origin (Bioenhancers) that Modulate Drug Membrane Permeation and Pre-Systemic Metabolism

  2019cites this paper
• Natural products as multidrug resistance modulators in cancer.

  2019cites this paper
• Kaempferol: A Key Emphasis to Its Anticancer Potential

  2019cites this paper
• Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids

  2019cites this paper
• Casein nanoparticles in combination with 2-hydroxypropyl-β-cyclodextrin improves the oral bioavailability of quercetin.

  2019cites this paper
• QUERCETIN IMPROVES THE EFFICACY OF SORAFENIB IN TRIPLE NEGATIVE BREAST CANCER CELLS THROUGH THE MODULATION OF DRUG EFFLUX TRANSPORTERS EXPRESSIONS

  2019cites this paper
• Quantitative Structure⁻Activity Relationships for the Flavonoid-Mediated Inhibition of P-Glycoprotein in KB/MDR1 Cells.

  2019cites this paper
• Tackling drug resistance with efflux pump inhibitors: from bacteria to cancerous cells

  2019cites this paper
• Prospects for the involvement of cancer stem cells in the pathogenesis of osteosarcoma

  2019cites this paper
• Combination of flavonoids with azole drugs for fungal infections: key pharmacokinetic challenges.

  2019cites this paper
• Leishmaniasis control: limitations of current drugs and prospects of natural products

  2019cites this paper
• Anti-cancer Foods: Flavonoids

  2019cites this paper
• Targeting multidrug resistance in cancer by natural chemosensitizers

  2019cites this paper
• Kaempferol increases apoptosis in human acute promyelocytic leukemia cells and inhibits multidrug resistance genes

  2018cites this paper
• Taxifolin Resensitizes Multidrug Resistance Cancer Cells via Uncompetitive Inhibition of P-Glycoprotein Function

  2018cites this paper
• Preparation of magnetic fluorescent dual-drug nanocomposites for codelivery of kaempferol and paclitaxel

  2018cites this paper
• Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery

  2017cites this paper
• Low dose of kaempferol suppresses the migration and invasion of triple-negative breast cancer cells by downregulating the activities of RhoA and Rac1

  2017cites this paper
• Rhinacanthin‐C enhances doxorubicin cytotoxicity via inhibiting the functions of P‐glycoprotein and MRP2 in breast cancer cells

  2017cites this paper
• Extending the structure-activity relationship study of marine natural ningalin B analogues as P-glycoprotein inhibitors.

  2017cites this paper
• Quercetin loaded nanoformulations for therapeutic purposes: a review

  2017cites this paper
• Assessing the anticancer effects associated with food products and/or nutraceuticals using in vitro and in vivo preclinical development-related pharmacological tests.

  2017cites this paper
• Engineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumors.

  2017cites this paper
• Drug resistance in leukemia: Remediation by natural means

  2017cites this paper
• low dose of kaempferol suppresses the migration and invasion of triple-negative breast cancer cells by downregulating the activities of rhoa and rac1

  2017cites this paper
• Efflux-Mediated Drug Resistance in Staphylococcus aureus

  2017cites this paper
• Investigating the Antiangiogenic, Anti-drug Resistance and Apoptotic Effects of Soy Isoflavone Extract Alone or in Combination with Docetaxel on Murine 4T1 Breast Tumor Model

  2017cites this paper
• Cytochrome P450 and P-Glycoprotein-Mediated Interactions Involving African Herbs Indicated for Common Noncommunicable Diseases

  2017cites this paper
• Pancreatic Cancer Stem Cells and Therapeutic Approaches.

  2017cites this paper
• Phytochemicals - A Novel and Prominent Source of Anti-cancer Drugs Against Colorectal Cancer.

  2017cites this paper
• Master and servant: Regulation of auxin transporters by FKBPs and cyclophilins.

  2016cites this paper
• In Vivo Exposure of Kaempferol Is Driven by Phase II Metabolic Enzymes and Efflux Transporters

  2016cites this paper
• The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters.

  2016cites this paper
• Transporter modulation by Chinese herbal medicines and its mediated pharmacokinetic herb-drug interactions.

  2016cites this paper
• Eff ect of quercetin on the transport of ritonavir to the central nervous system in vitro and in vivo

  2016cites this paper
• Natural Polyphenols in Cancer Chemoresistance

  2016cites this paper
• Advances in plant-based inhibitors of P-glycoprotein

  2016influential citation
• Structural implications of polyphenolic antioxidants

  2016cites this paper
• Multi-Drug Resistance Transporters and a Mechanism-Based Strategy for Assessing Risks of Pesticide Combinations to Honey Bees

  2016cites this paper
• Natural flavonoids silymarin and quercetin improve the brain distribution of co-administered P-gp substrate drugs

  2016cites this paper
• Prediction and characterization of P-glycoprotein substrates potentially bound to different sites by emerging chemical pattern and hierarchical cluster analysis.

  2016cites this paper